Neoantigen Peptides

BIOLOGICAL2 trials

Sponsors

Instituto de Medicina Regenerativa

Conditions

Neoplasms

Early Phase 1

Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms

CompletedNCT04509167

Instituto de Medicina RegenerativaNeoplasms

Start: 2020-08-10End: 2022-06-24Updated: 2024-03-06

Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms

RecruitingNCT05475106

Instituto de Medicina RegenerativaNeoplasms

Start: 2022-05-12End: 2026-06-20Target: 100Updated: 2024-03-06